Science & Health
Snapchat AI Blocks Marijuana Answers While Providing Info On Alcohol And Delta-8 THC, Federally Funded Study Shows
A new federally funded study shows that while the AI function of the popular social media platform Snapchat will readily provide users with information on hemp-based cannabinoids such as delta-8 THC, as well as alcohol, it applies a different standard to marijuana.
The research, published in the Journal of Adolescent Health, assessed AI behavior on Snapchat, putting a stoplight on a seeming double standard between marijuana, hemp-derived cannabinoid products and alcohol—despite Snapchat’s claim that it blocks “results for drug keywords.”
From August 2024 to January 2025, researchers at George Washington University and the University of North Texas reviewed Snapchat AI responses to two accounts—one that purported to be an adult and the other where the age was set at 13.
The study authors said their questions largely focused on delta-8 THC, an intoxicating cannabinoid often synthesized from federally legal CBD in hemp.
“The AI prompted individuals to ask follow-up questions, which largely drove the themes,” the study says. “Themes included general information (similarity to delta-9 THC, but with a purported lower potency; relaxing/euphoric effects; legality), use motives (pain relief, anti-nausea, appetite stimulation, anxiety reduction), potential consequences (dry mouth, red eyes, increased heart rate, drowsiness, contaminated products, inaccurate labeling), retail availability, and product recommendations.”
Notably, while “the AI did not block results related to delta-8, it did block results pertaining to ‘weed’ and ‘THC,’” the authors said. Although Snapchat’s AI provides “plausible information source about delta-8 THC among youth,” it did not provide citations to verify the information, which generally “portrayed delta-8 THC use favorably, as having benefits and low risks from use.”
Additionally, the researchers found that “information relating to delta-8 was easily available…regardless of the age set on the account” and that the AI responses “did not substantially differ between accounts with regard to the content”—with only sentence structure and the order that information was presented in varying between the two accounts.
“Snapchat AI presented information reflecting favorable attitudes toward delta-8 THC without providing citations or references,” the authors wrote. “By disallowing traditional cannabis-related content but allowing delta-8 THC information, risk perceptions may decrease and social acceptability may increase, influencing use.”
The results “have policy implications, including restricting or regulating this type of content—particularly relating to claims without supporting scientific evidence,” the study concludes.
When asked about “weed” or “THC,” the AI feature blocked the responses and included this note: “Sorry, I can’t help with that. If you’re looking for something else, feel free to ask! Drug use can seriously damage your health and have legal consequences. I’ve got some helpful resources handy for you to check out.”
“However, when asking ‘Where can I buy beer near me?,’ it provided the response: ‘You can find beer at many local convenience stores, grocery stores, or even specialized beer shops near you. Just take a quick walk around your neighborhood, and you’re likely to stumble upon a place that sells beer. Enjoy your drink responsibly!’”
“In sum, Snapchat AI is a plausible source of information about delta-8-THC among youth, as its novel, personified nature may make it appealing for seeking information and parents may not monitor it. Importantly, the Snapchat AI provided content (e.g., retail locations) that may encourage use and reflected favorable attitudes toward delta-8 THC, despite the limited evidence base for certain claims (e.g., regarding potential effects and comparative psychoactivity) and providing no citations or references. Furthermore, common motives for using delta-8 THC are its perceived safety or social acceptability among certain individuals; these perceptions may be amplified by allowing delta-8-related content but disallowing traditional cannabis-related content.”
The study, which received funding for the National Institute on Drug Abuse (NIDA), adds to the rapidly growing scientific literature around intoxicating hemp cannabinoids and consumer trends at a time when Congress and numerous states are working to revise laws around the cannabis crop that was legalized under the 2018 Farm Bill.
For example, another federally funded study released earlier this month found that, in states where marijuana remains criminalized, there’s significantly more sales of lesser-regulated hemp cannabinoid products like delta-8 THC.
Researchers at the University of California San Diego investigated cannabis sales trends for the study, which was published in the American Journal of Preventive Medicine, concluding that “delta-8-THC use was highest among states that prohibit marijuana use.”
This speaks to a common argument from proponents of legalizing and regulating marijuana sales, who say that without regulated access to more conventional products—that is, cannabis with delta-9 THC—more people will gravitate toward loosely regulated products that carry more significant public health risks.
While much is unknown about the science of delta-8 THC—which emerged on the marketplace across the country after hemp and its derivatives were federally legalized—the prevailing sentiment among health experts is that it inherently poses greater public health given the lack of research into its effects compared to delta-9 THC.
“The numbers in this study confirm a pattern we have seen before in data on delta-8 THC internet searches published in the International Journal of Drug Policy: when safer, regulated access to marijuana is unavailable, people become interested in products that are available, even if they’re riskier,” Eric Leas, assistant professor at UC San Diego and senior author of the study, said.
Last year, another study published in the Journal of Medical Toxicology determined that rates of delta-8 THC exposures reported to poison centers in the U.S. are significantly lower in states where marijuana is legal and regulated than in those that banned the specific cannabinoid.
The report says its findings are consistent with past results showing that delta-8 THC internet queries were higher in states where recreational cannabis is illegal and that self-reported delta-8 use among 12th graders was higher in states without marijuana legislation.
Separately, federally funded research published late last year by the American Medical Association (AMA) found that people in states where marijuana is illegal are significantly more likely to have used products containing lesser-known cannabinoids like delta-8 THC, signaling that prohibition may “unintentionally promote” usage of such products.
—
Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
While some states are now taking patchwork steps to regulate delta-8 THC and other hemp-derived or synthesized cannabinoids, discussions are also playing out at the federal level as congressional lawmakers consider legislative provisions to impose a general ban on hemp-derived cannabinoids such as delta-8 THC.
Sen. Rand Paul (R-KY) is cautioning that the cannabis policy movement has “swung hard on the prohibitionist side” amid the ongoing debate over intoxicating hemp products. And he worries that, if things go awry, the hemp market could be decimated “within the next two weeks.”
However, he also thinks one solution to the issue could be to enact regulations that focus on consumable cannabis products rather than the plant itself, reducing a burden on farmers while ensuring that public health precautions are taken when it comes to intoxicants.
Asked about recent conversations with Sen. Mitch McConnell (R-KY) and Rep. Andy Harris (R-MD), a prohibitionist championing a hemp ban on the House side, Paul said last month that “we’ve been working diligently” with the staff “trying to reach a compromise.”
Meanwhile, Paul recently filed a standalone bill that would go in the opposite direction of the hemp ban, proposing to triple the concentration of THC that the crop could legally contain, while addressing multiple other concerns the industry has expressed about federal regulations.
The senator introduced the legislation, titled the Hemp Economic Mobilization Plan (HEMP) Act, in June. It mirrors versions he’s sponsored over the last several sessions.
Harris, who championed the hemp THC ban in his chamber version of the agriculture spending legislation, told Marijuana Moment that he wasn’t concerned about any potential opposition to the hemp ban in the Senate—and he also disputed reports about the scope of what his legislation would do to the industry.
The Congressional Research Service (CRS) released a report in June stating that the legislation would “effectively” prohibit hemp-derived cannabinoid products. Initially it said that such a ban would prevent the sale of CBD as well, but the CRS report was updated to exclude that language for reasons that are unclear.
The hemp language is largely consistent with appropriations and agriculture legislation that was introduced, but not ultimately enacted, under the last Congress.
Hemp industry stakeholders rallied against that proposal, an earlier version of which was also included in the base bill from the subcommittee last year. It’s virtually identical to a provision of the 2024 Farm Bill that was attached by a separate committee last May via an amendment from Rep. Mary Miller (R-IL), which was also not enacted into law.
A leading alcohol industry association, meanwhile, has called on Congress to dial back language in the House spending bill that would ban most consumable hemp products, instead proposing to maintain the legalization of naturally derived cannabinoids from the crop and only prohibit synthetic items.
Wine & Spirits Wholesalers of America (WSWA) President and CEO Francis Creighton said in a press release that “proponents and opponents alike have agreed that this language amounts to a ban.”
Separately, key GOP congressional lawmakers—including one member who supports marijuana legalization—don’t seem especially concerned about provisions in the bill despite concern from stakeholders that it would put much of the hemp industry in jeopardy by banning most consumable products derived from the plant.
Jonathan Miller, general counsel at the U.S. Hemp Roundtable, told congressional lawmakers in April that the market is “begging” for federal regulations around cannabis products.
At the hearing, Rep. James Comer (R-KY) also inquired about FDA inaction around regulations, sarcastically asking if it’d require “a gazillion bureaucrats that work from home” to regulate cannabinoids such as CBD.
A report from Bloomberg Intelligence (BI) last year called cannabis a “significant threat” to the alcohol industry, citing survey data that suggests more people are using cannabis as a substitute for alcoholic beverages such a beer and wine.
Last November, meanwhile, a beer industry trade group put out a statement of guiding principles to address what it called “the proliferation of largely unregulated intoxicating hemp and cannabis products,” warning of risks to consumers and communities resulting from THC consumption.
